Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 7429572 Modified fluorinated nucleoside analogues

Patent 7429572 was granted and assigned to Pharmasset on September, 2008 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributorsActivity
Is a
Patent
Patent
Current Assignee
Pharmasset
Pharmasset
Date Filed
April 21, 2004
Date of Patent
September 30, 2008
Patent Application Number
10828753
Patent Citations Received
‌
US Patent 12121529 Nucleoside phosphoramidate prodrugs
0
‌
US Patent 11975016 2′-substituted-N
0
‌
US Patent 12006340 Nucleotide hemi-sulfate salt for the treatment of hepatitis c virus
0
‌
US Patent 12084473 β-D-2′-deoxy-2′-α-fluoro-2′-β-C-substituted-2-modified-N6-substituted purine nucleotides for HCV treatment
0
‌
US Patent 11707480 Highly active compounds against COVID-19
0
‌
US Patent 11707479 Combination formulation of two antiviral compounds
0
‌
US Patent 11970482 Acetal compounds and therapeutic uses thereof
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent Number
7429572
Patent Primary Examiner
‌
Shaojia Anna Jiang

Find more entities like US Patent 7429572 Modified fluorinated nucleoside analogues

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo
By using this site, you agree to our Terms of Service.